{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:20:02Z","timestamp":1715984402820},"reference-count":7,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.dsx.2012.09.009","type":"journal-article","created":{"date-parts":[[2012,10,18]],"date-time":"2012-10-18T05:48:21Z","timestamp":1350539301000},"page":"173-174","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and safety of statin and fibrate combination therapy in lipid management"],"prefix":"10.1016","volume":"6","author":[{"given":"Sunil Kumar","family":"Kota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalit Kumar","family":"Meher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Epari Sanjeeva","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sruti","family":"Jammula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirtikumar D.","family":"Modi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2012.09.009_bib0005","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2147\/VHRM.S3390","article-title":"Update on the clinical utility of fenofibrate in mixed dyslipidemias: mechanisms of action and rational prescribing","volume":"4","author":"Farnier","year":"2008","journal-title":"Vascular Health and Risk Management"},{"key":"10.1016\/j.dsx.2012.09.009_bib0010","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1185\/03007995.2011.569018","article-title":"Evaluating optimal lipid levels in patients with mixed dyslipidemia following short- and long-term treatment with fenofibric acid and statin combination therapy: a post hoc analysis","volume":"27","author":"Mohiuddin","year":"2011","journal-title":"Current Medical Research and Opinion"},{"issue":"Suppl. 1","key":"10.1016\/j.dsx.2012.09.009_bib0015","first-page":"S56","article-title":"Clinical practice recommendations 1999","volume":"22","author":"American Diabetes Association","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2012.09.009_bib0020","first-page":"525","article-title":"Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid","volume":"6","author":"Moutzouri","year":"2010","journal-title":"Vascular Health and Risk Management"},{"key":"10.1016\/j.dsx.2012.09.009_bib0025","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.atherosclerosis.2010.05.027","article-title":"Plasma PCSK9 is increased by fenofibrate and atorvastatin in a non-additive fashion in diabetic patients","volume":"212","author":"Costet","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.dsx.2012.09.009_bib0030","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/ATVBAHA.108.170530","article-title":"Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome","volume":"28","author":"Chan","year":"2008","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.dsx.2012.09.009_bib0035","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.2337\/dc10-0272","article-title":"Pleiotropic effects of atorvastatin and fenofibrate in metabolic syndrome and different types of pre-diabetes","volume":"33","author":"Krysiak","year":"2010","journal-title":"Diabetes Care"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402112001555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402112001555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T03:24:38Z","timestamp":1542684278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402112001555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1871402112001555"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2012.09.009","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}